|
|
| |
 |
Reassortant between human-like H3N2 and avian H5 subtype influenza A viruses in pigs: a potential public health risk
|
|
|
Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence
From Pediatrics, published online Sep 6
|
|
|
Pandemic influenza control in Europe and the constraints resulting from incoherent public health laws
From BMC Public Health, published Sep 3
|
|
|
Perceptions of immunization information systems for collecting pandemic H1N1 immunization data within Canada's public health community: a qualitative study
From BMC Public Health, published Aug 31
|
|
|
Do as I say, not as I do: handwashing compliance of infectious diseases experts during influenza pandemic
From Sep Am J Infect Control
|
|
|
Facial protective equipment, personnel, and pandemics: impact of the pandemic (H1N1) 2009 virus on personnel and use of facial protective equipment
From Infect Control Hosp Epidemiol, published online Aug 23
|
|
|
Pandemic influenza--(some) reasons to be cheerful?
Editorial from Aug 21 Lancet
|
|
|
The public health emergency medical countermeasures enterprise review
HHS report released Aug 19
|
|
|
Quantifying exposure risk: surgical masks and respirators
From Sep Am J Infect Control
|
|
|
Biennial implementation plan for the national health security strategy of the United States of America
DHHS Report released Jul 19
|
|
|
The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns
From Vaccine, published online Aug 14
|
|
|
Assessing physicians' in training attitudes and behaviors during the 2009 H1N1 influenza season: a cross-sectional survey of medical students and residents in an urban academic setting
From Sep Influenza Other Respi Viruses
|
|
|
The effect of mask use on the spread of influenza during a pandemic
|
|
|
The end of the pandemic--what will be the pattern of influenza in the 2010-11 European winter and beyond?
Editorial from Aug 12 Euro Surveill
|
|
|
H1N1 in post-pandemic period
WHO statement released Aug 10
|
|
|
WHO recommendations for the post-pandemic period
WHO pandemic (H1N1) 2009 briefing note published Aug 10
|
|
|
Director-general statement following the ninth meeting of the emergency committee
WHO statement released Aug 10
|
|
|
What is post-pandemic?
FAQ from WHO, published Aug 10
|
|
|
Emerging, novel, and known influenza virus infections in humans
From Sep Infect Dis Clin North Am
|
|
|
Knowledge, attitudes and practices towards pandemic influenza among cases, close contacts, and healthcare workers in tropical Singapore: a cross-sectional survey
From Jul 28 BMC Public Health
|
|
|
An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006
From Sep Epidemiol Infect
|
|
|
Developing guidelines for school closure interventions to be used during a future influenza pandemic
From Jul 27 BMC Infect Dis
|
|
|
Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic
|
|
|
Characterizing hospital workers' willingness to report to duty in an influenza pandemic through threat- and efficacy-based assessment
From Jul 26 BMC Public Health
|
|
|
Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 17-18 February 2010
From Vaccine, published online Jul 25
|
|
|
An alternative approach to pandemic influenza that clinicians everywhere could use
Editorial from Clinicians' Biosecurity Network, published online Jul 23
|
|
|
PB1-F2 proteins from H5N1 and 20th century pandemic influenza viruses cause immunopathology
|
|
|
Monitoring influenza activity in Europe with Google flu trends: comparison with the findings of sentinel physician networks -- results for 2009-10
From Jul 22 Euro Surveill
|
|
|
Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian experience
From Vaccine, published online Jul 17
|
|
|
Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial
From Vaccine, published online Jul 16
|
|
|
WHO: Confirmed Human Cases of Avian Influenza A (H5N1)
|
|
